Bee Vectoring Technologies Engages Lytham Partners to Lead U.S. Investor Relations and Shareholder Communication Program

Press Releases
Posted on June 11, 2020

Bee Vectoring Technologies Engages Lytham Partners to Lead U.S. Investor Relations and Shareholder Communication Program

Mississauga, Ontario and Sacramento, California– June 11, 2020 –  Bee Vectoring Technologies International Inc. (TSXV: BEE) (OTCQB: BEVVF) (CVE: BEE) (the “Company” or “BVT”), a leading agriculture technology company that has pioneered a natural precision agriculture system, today announced it has retained Lytham Partners, LLC (“Lytham Partners”) to lead a U.S. investor relations and shareholder communication program.

Lytham Partners has been one of America’s leading investor relations firms for over 20 years and has one of the industry’s largest and most diverse networks of institutional investors. The firm provides expertise and guidance to small-capitalization companies in the healthcare, technology, services, agricultural, industrial, aerospace and defense segments, as well as the consumer and capital goods industries.

Ashish Malik, CEO of BVT commented, “We have made significant progress over the past year advancing our next generation biologic delivery system, including the recent U.S. Environmental Protection Agency’s approval of our proprietary Clonostachys rosea CR-7 (CR-7) for use as a fungicide on commercial crops, and the  initial commercial launch of the product into the strawberry and blueberry crop markets. As we continue to make progress in expanding our addressable market opportunity through additional crop, country and product approvals, we believe the timing is appropriate to expand our awareness within the U.S. investment community. We look forward to working with the team at Lytham Partners, which has a strong understanding of the AgTech market, to further assist us in these efforts.”

Adam Lowensteiner, Vice President of Lytham Partners  said, “As one of the few public companies in the AgTech space, we believe the U.S. investment community will be interested to learn more about BVT’s unique value proposition and opportunities ahead to continue creating value for shareholders. We look forward to introducing the Company to our platform of investors, while installing best practices within their communications program at all levels to keep shareholders apprised of the developments taking place at the Company.”

In connection with the engagement, Lytham Partners has been awarded a six-month consulting contract which can be extended on a quarter-by-quarter basis. The contract includes a quarterly fee of US$15,000 and the ability to receive 50,000 restricted stock units.

About Lytham Partners

For more than 20 years, Lytham Partners has been one of the country’s leading investor relations firms, having created one of the industry’s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with many of the industry’s most respected institutional investors, Lytham Partners has spent the past two decades creating an integrated platform that allows its clients far reaching exposure to investors in a consistent and in-depth format. This platform is matched with a communications and positioning approach that is streamlined throughout press releases, conference calls, investor presentations, corporate profiles, and websites. For more information visit our website at

Bee Vectoring Technologies International Inc.

BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT’s award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides – and improving the health of the soil, the microbiome and the environment. Currently, BVT has over 65 granted patents, over 35 patents pending in all major agricultural countries worldwide, and has US EPA registration of its VECTORITE™ with CR-7 (EPA Registration No. 90641-2) for sale as a registered biological fungicide for use on the labeled crops.

Additional information can be viewed at the Company’s website To receive regular news updates from the Company, subscribe at

Ashish Malik, President & CEO

Babak Pedram, Investor Relations
Virtus Advisory Group
Tel: 416-995-8651

Adam Lowensteiner
Phoenix | New York
Telephone: 646-829-9700

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to the Company, “annual revenue potential”, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions, including: planted acres of strawberries in Florida, selling price of competitive chemical pesticides and the US to Canadian dollar exchange rate. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include changes in law, competition, litigation, the ability to implement business strategies and pursue business opportunities, state of the capital markets, the availability of funds and resources to pursue operations, new technologies, the ability to protect intellectual property rights, the ability to obtain patent protection for products, third-party intellectual property infringement claims, regulatory changes affecting products, failing research and development activities, the ability to reach and sustain profitability, dependence on business and technical experts, the ability to effectively manage business operations and growth, issuance of debt, dilution of existing securities, volatility of publicly traded securities, potential conflicts of interest, unlikelihood of dividend payments, the potential costs stemming from defending third-party intellectual property infringement claims, the ability to secure relationships with manufacturers and purchasers, as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company’s Filing Statement dated May 29, 2015, filed with the securities regulatory authorities in certain provinces of Canada and available at Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. All figures are in Canadian dollars.